Related Experiment Video
Updated: Mar 2, 2026

03:56
A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
Published on: September 13, 2022
3.0K
Predicting Success in Percutaneous Transhepatic Biliary Drainage
Ankaj Khosla1, Yin Xi1, Seth Toomay2
1Department of Radiology, University of Texas, Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.
Cardiovascular and Interventional Radiology
|May 14, 2017
Summary
This study developed a predictive model for bilirubin reduction after percutaneous transhepatic biliary drain placement (PTBD). The model identifies patients who may not benefit from PTBD, aiding clinical decisions.
Area of Science:
- Medical Imaging and Interventional Radiology
- Hepatology
- Predictive Analytics in Medicine
Background:
- Percutaneous transhepatic biliary drain placement (PTBD) is a common procedure for biliary obstruction.
- Predicting treatment success is crucial for optimizing patient care and resource allocation.
- Accurate prediction of bilirubin decrease post-PTBD can guide therapeutic decisions, especially in cases of malignant obstruction.
Purpose of the Study:
- To develop and validate a predictive model for successful bilirubin reduction following PTBD.
- To identify key clinical variables associated with bilirubin decrease after PTBD.
- To assist clinicians in determining patient suitability for PTBD, particularly in malignant biliary obstruction.
Main Methods:
- Retrospective analysis of 190 patients who underwent PTBD between 2002 and 2013.
- Development of a regression model using logarithm-transformed variables to predict post-drainage total bilirubin levels.
- Utilized stepwise variable selection (Schwarz Bayesian Information Criterion) and Monte Carlo simulation for model validation.
Main Results:
- Initial total bilirubin (PrTbl), INR, and ALT were identified as the strongest predictors of bilirubin reduction.
- The developed model demonstrated a root mean squared error of 0.8.
- The model achieved a negative predictive value of 83% for predicting post-drainage bilirubin levels below 2 mg/dL.
Conclusions:
- PTBD may not effectively decrease bilirubin levels in patients with malignant biliary obstruction.
- The developed model serves as an initial tool to identify patients unlikely to benefit from PTBD.
- Further validation with larger patient cohorts can enhance the model's clinical utility for patient care decisions.
